(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-bis[(R)-1-phenylethyl]amine, min. 98% (S)-SIPHOS-PE
15-5163 / 500mg
CAS No.:500997-70-6
racemic-8,8'-Bis(diphenylphosphino)-3,3',4,4'-tetrahydro-4,4,4',4',6,6'-hexamethyl-2,2'-spirobi[2H-1-benzopyran], min. 95% SPANphos
15-5165 / 100mg
CAS No.:556797-94-5
racemic-8,8'-Bis(diphenylphosphino)-3,3',4,4'-tetrahydro-4,4,4',4',6,6'-hexamethyl-2,2'-spirobi[2H-1-benzopyran], min. 95% SPANphos
15-5165 / 500mg
CAS No.:556797-94-5
(R)-(+)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-Xyl-SDP
15-5168 / 100mg
CAS No.:917377-75-4
(R)-(+)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-Xyl-SDP
15-5168 / 25mg
CAS No.:917377-75-4
(S)-(-)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-Xyl-SDP
15-5169 / 100mg
CAS No.:528521-89-3
(S)-(-)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-Xyl-SDP
15-5169 / 25mg
CAS No.:528521-89-3
(R)-(+)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-SDP
15-5174 / 100mg
CAS No.:917377-74-3
(R)-(+)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-SDP
15-5174 / 25mg
CAS No.:917377-74-3
(S)-(-)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-SDP
15-5175 / 100mg
CAS No.:528521-86-0
(S)-(-)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-SDP
15-5175 / 25mg
CAS No.:528521-86-0
(R)-(+)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-Tol-SDP
15-5180 / 100mg
CAS No.:528521-87-1
(R)-(+)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-Tol-SDP
15-5180 / 25mg
CAS No.:528521-87-1
(S)-(-)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-Tol-SDP
15-5181 / 100mg
CAS No.:817176-80-0
(S)-(-)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-Tol-SDP
15-5181 / 25mg
CAS No.:817176-80-0
(11aR)-(+)-5,6,10,11,12,13-Hexahydro-5-phenyl-4H-diindeno[7,1-cd:1’,7’-ef]phosphocin, min. 97% (R)-SITCP
15-5184 / 100mg
CAS No.:856407-37-9
(11aR)-(+)-5,6,10,11,12,13-Hexahydro-5-phenyl-4H-diindeno[7,1-cd:1’,7’-ef]phosphocin, min. 97% (R)-SITCP
15-5184 / 25mg
CAS No.:856407-37-9
(11aS)-(+)-5,6,10,11,12,13-Hexahydro-5-phenyl-4H-diindeno[7,1-cd:1’,7’-ef]phosphocin, min. 97% (S)-SITCP
15-5185 / 100mg
CAS No.:885701-78-0
(11aS)-(+)-5,6,10,11,12,13-Hexahydro-5-phenyl-4H-diindeno[7,1-cd:1’,7’-ef]phosphocin, min. 97% (S)-SITCP
15-5185 / 25mg
CAS No.:885701-78-0
(R)-(+)-7-[4(S)-(Benzyl)oxazol-2-yl]-7'-diphenylphosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S)-Ph-Bn-SIPHOX
15-5186 / 100mg
CAS No.:2074610-05-0
(R)-(+)-7-[4(S)-(Benzyl)oxazol-2-yl]-7'-diphenylphosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S)-Ph-Bn-SIPHOX
15-5186 / 25mg
CAS No.:2074610-05-0
(S)-(-)-7-[4(S)-(Benzyl)oxazol-2-yl]-7-diphenylphosphino-2,2’,3,3’-tetrahydro-1,1'-spirobiindane, min. 97% (Sa,S)-Ph-Bn-SIPHOX
15-5187 / 100mg
CAS No.:913829-88-6
(S)-(-)-7-[4(S)-(Benzyl)oxazol-2-yl]-7-diphenylphosphino-2,2’,3,3’-tetrahydro-1,1'-spirobiindane, min. 97% (Sa,S)-Ph-Bn-SIPHOX
15-5187 / 25mg
CAS No.:913829-88-6
(R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine, min. 97% CTH-(R)-P-Phos
15-5200 / 100mg
CAS No.:221012-82-4
(R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine, min. 97% CTH-(R)-P-Phos
15-5200 / 500mg
CAS No.:221012-82-4
(S)-(-)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine, min. 95% CTH-(S)-P-Phos
15-5201 / 100mg
CAS No.:362524-23-0
(S)-(-)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine, min. 95% CTH-(S)-P-Phos
15-5201 / 500mg
CAS No.:362524-23-0
(R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine, min. 97% CTH-(R)-Xylyl-P-PHOS
15-5210 / 100mg
CAS No.:442905-33-1
(R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine, min. 97% CTH-(R)-Xylyl-P-PHOS
15-5210 / 500mg
CAS No.:442905-33-1
(S)-(-)-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine, min. 95% CTH-(S)-Xylyl-P-Phos
15-5211 / 100mg
CAS No.:443347-10-2
(S)-(-)-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine, min. 95% CTH-(S)-Xylyl-P-Phos
15-5211 / 500mg
CAS No.:443347-10-2
1,3,5,7-Tetramethyl-8-phenyl-2,4,6-trioxa-8-phosphaadamantane, 99% MeCgPPh
15-5355 / 2g
CAS No.:97739-46-3
1,3,5,7-Tetramethyl-8-phenyl-2,4,6-trioxa-8-phosphaadamantane, 99% MeCgPPh
15-5355 / 500mg
CAS No.:97739-46-3
(11bR)-N-Methyl-N-[(R)-1-phenylethyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98%
15-5610 / 50mg
CAS No.:1021439-57-5
(11bS)-N,N-Bis[(S)-1-phenylethyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98%, (99% ee)
15-5614 / 100mg
CAS No.:209482-27-9